Sage Journals: Discover world-class research

Abstract

A microplate-based electrophoretic assay has been developed for the serine/threonine kinase protein kinase A (PKA). The ElectroCapture™ PKA assay developed uses a positively charged, lissamine-rhodamine–labeled kemptide peptide substrate for the kinase reaction and Nanogen’s ElectroCapture™ HTS Workstation and 384-well laminated membrane plates to electrophoretically separate the negatively charged phosphorylated peptide product from the kinase reaction mix. After the electrophoretic separation, the amount of rhodamine-labeled phosphopeptide product was quantified using a Tecan Ultra384 fluorescence reader. The ElectroCapture™ PKA assay was validated with both known PKA inhibitors and library compounds. The pK_iapp results obtained in the ElectroCapture™ PKA assay were comparable to those generated with current radioactive filter-binding assay and antibody-based competitive fluorescence polarization PKA assay formats.

Keywords

ElectroCapture™protein kinase A PKA fluorescence polarization FP

References

Cohen P : Protein kinases: the major drug targets of the twenty-first century? Nat Rev Drug Discov 2002;1:493-502.

Manning G , Whyte DB , Martinez R , Hunter T , Sudarsanam S : The protein kinase complements of the human genome: Science 2002;298:1912-1934.

Casnellie JE : Assay of protein kinases using peptides with basic residues for phosphocellulose binding. Meth Enzymol 1991;200:115-120.

Sittampalam GS , Kahl SD , Janzen WP : High-throughput screening: advances in assay technologies. Curr Opin Chem Biol 1997;1:384-391.

Fitzgerald DA : Escaping the heat. Scientist 2000;November 13:23-26.

Lesney MS : Focus on phosphate: high-throughput screening improves the odds by using kinases as targets for drug discovery. Modern Drug Discov 2003;May:38-45.

Coty C : Detection technologies vital to assay success. Drug Discov Devel 2002;July/August:44-51.

Hemmila IA , Hurskainen P : Novel detection strategies for drug discovery. Drug Discov Today 2002;18(suppl.):150-156.

Shabb JB : Physiological substrates of cAMP-dependent protein kinase. Chem Rev 2001;101:2381-2411.

10.

Kemp BE , Graves DJ , Benjamini E , Krebs EG : Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J Biol Chem 1977;252:4888-4894.

11.

Wu JJ , Yarwood DR , Pham Q , Sills MA : Identification of a high-affinity anti-phosphoserine antibody for the development of a homogenous fluorescence polarization assay of protein kinase C. J Biol Chem 2000;5:23-30.

12.

Cheng Y , Prusoff WH : Relationship between the inhibition constant (Ki)and the concentration of inhibitor which causes 50 per cent inhibition (I50)ofan enzymatic reaction. Biochem Pharmacol 1973;22:3099-3108.

13.

Whitehouse S , Feramisco JR , Casnellie JE , Krebs EG , Walsh DA : Studies on kinetic mechanism of the catalytic subunit of the cAMP-dependent protein kinase. J Biol Chem 1983;258:3693-3701.

14.

Wecker L , Rogers CQ : Phosphorylation sites within alpha4 subunits of alpha4beta2 neuronal nicotinic receptors: a comparison of substrate specificities for cAMP-dependent protein kinase (PKA) and protein kinaseC (PKC). Neurochem Res 2003;28:431-436.

15.

Grant BD , Adams JA : Pre-steady-state kinetic analysis of cAMP-dependent protein kinase using rapid quench flow techniques. Biochemistry 1996; 35:2022-2029.

16.

Lew J , Coruh N , Tsigelny I , Garrod S , Taylor SS : Synergistic binding of nucleotides and inhibitors to cAMP-dependent protein kinase examined by acrylodan fluorescence spectroscopy. J Biol Chem 1997;272:1507-1513.

17.

Grant BD , Hemmer W , Tsigelny I , Adams JA , Taylor SS : Kinetic analyses of mutations in the glycine-rich loop of cAMP-dependent protein kinase. Biochemistry 1998;37:7708-7715.

18.

Moore MJ , Adams JA , Taylor SS : Structural basis for peptide binding in protein kinase A: role of glutamic acid 203 and tyrosine 204 in the peptide-positioning loop. J Biol Chem 2003;278:10613-10618.

19.

Owicki JC : Fluorescence polarization and anisotropy in high throughput screening: perspective and primer. J Biomol Screen 2000;5:297-306.

20.

Sportsman JR , Lee SK , Dilley H , Bukar R : Fluorescence polarization. In Devlin J (ed): High Throughput Screening: The Discovery of Bioactive Substances. New York: Marcel Dekker, 1997:389-400.

21.

Loomans EMG , van Doornamlen AM , Wat JWY , Zaman GRR : High-throughput screening with immobilized metal ion affinity-base fluorescence polarization detection, a homogenous assay for protein kinases. Assay Drug Develop Technol 2003;1:445-453.

22.

Sittampalam GS , Iversen PW , Boadt JA , Kahl SD , Bright S , Zock JM , et al: Design of signal windows in high throughput screening assays for drug discovery. J Biomol Screen 1997;2:159-169.

23.

Zhang JH , Chung TD , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.

24.

Willson P : Nanogen ElectroCapture™, a novel antibody-free kinase assay format. Paper presented at the IBC-Life Sciences Conference: Protein Kinases, London, 2003.

25.

Huss KL , Campbell RM : Evaluation of the Z’LYTE™ technology for S/T kinase assays: comparison with two other formats for lead optimization of protein kinase A inhibitors [Poster 10044]. Paper presented at the 10th annual meeting of the Society for Biomolecular Screening, Orlando, September 2004.

26.

Miick SM : Electronic, fluorescent kinase assays for HTS. Paper presented at the Lab Robotics Interest Group, San Diego, 2003.

27.

Miick SM : An electronic, fluorescent kinase assay. Paper presented at SRI: Protein Phosphorylation Drug Discovery World Summit, San Diego, 2003.

28.

Janssen D : The key to kinases is all in the kits. Drug Discov Devel 2002; April;28-32.

Development of a Microplate-Based,Electrophoretic Fluorescent Protein Kinase A Assay: Comparison with Filter-Binding and Fluorescence Polarization Assay Formats

Abstract

Keywords

References